US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 3.0999
  • +0.1699+5.80%
Close Sep 9 16:00 ET
8.40MMarket Cap1.93P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
83.13%-1.11M
69.89%-1.87M
86.47%-5.49M
301.77%14.21M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.21%-40.61M
18.39%-7.04M
-25.14%-9.92M
Net income from continuing operations
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
7.04%-10.5M
Depreciation and amortization
----
----
--0
--0
----
----
----
-86.23%65K
--0
--0
Change In working capital
101.16%32K
-262.42%-510K
-61.44%-4.6M
105.26%50K
-104.63%-2.21M
-422.37%-2.75M
118.78%314K
-302.41%-2.85M
-130.54%-951K
-219.05%-1.08M
-Change in receivables
----
----
2,300.00%96K
--0
--0
----
----
-85.19%4K
125.86%131K
--0
-Change in prepaid assets
140.25%192K
-43.70%134K
195.12%363K
205.58%284K
186.49%318K
-232.50%-477K
401.27%238K
209.82%123K
26.50%-269K
-45.59%111K
-Change in payables and accrued expense
93.81%-160K
-570.83%-644K
-60.24%-5.54M
71.73%-255K
-96.98%-2.61M
-815.79%-2.58M
93.98%-96K
-449.29%-3.46M
-127.38%-902K
-256.57%-1.32M
-Change in other current assets
--0
--0
0.00%481K
-76.40%21K
-41.98%76K
59.40%212K
34.38%172K
-68.99%481K
-30.47%89K
670.59%131K
Cash from discontinued investing activities
-15.75M
0
Operating cash flow
83.13%-1.11M
69.89%-1.87M
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.21%-40.61M
18.39%-7.04M
-25.14%-9.92M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
----
----
--10.4M
--0
--10.4M
----
----
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
17,224.14%5.02M
0
0
-99.91%29K
-85.88%12K
0
Net common stock issuance
----
----
----
----
--0
----
----
----
----
--0
Proceeds from stock option exercised by employees
----
----
17,224.14%5.02M
41,566.67%5M
--0
----
----
-89.72%29K
-85.88%12K
--0
Cash from discontinued financing activities
Financing cash flow
----
----
17,224.14%5.02M
--0
--0
----
----
-99.91%29K
-85.88%12K
--0
Net cash flow
Beginning cash position
-20.55%5.7M
-43.42%7.57M
-75.20%13.38M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
-7.33%53.96M
-67.35%20.41M
-56.92%30.32M
Current changes in cash
27.76%-1.11M
69.89%-1.87M
85.66%-5.82M
78.08%-1.54M
134.97%3.47M
85.83%-1.53M
51.59%-6.21M
-849.29%-40.58M
17.72%-7.03M
-25.71%-9.92M
Effect of exchange rate changes
-166.67%-2K
-500.00%-4K
166.67%8K
-50.00%4K
--0
400.00%3K
200.00%1K
-25.00%3K
166.67%8K
---3K
End cash Position
-18.67%4.59M
-20.55%5.7M
-43.42%7.57M
-43.42%7.57M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
-75.20%13.38M
-67.35%20.41M
Free cash flow
83.13%-1.11M
69.89%-1.87M
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.19%-40.61M
18.39%-7.04M
-25.03%-9.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 83.13%-1.11M69.89%-1.87M86.47%-5.49M301.77%14.21M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.21%-40.61M18.39%-7.04M-25.14%-9.92M
Net income from continuing operations 68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M7.04%-10.5M
Depreciation and amortization ----------0--0-------------86.23%65K--0--0
Change In working capital 101.16%32K-262.42%-510K-61.44%-4.6M105.26%50K-104.63%-2.21M-422.37%-2.75M118.78%314K-302.41%-2.85M-130.54%-951K-219.05%-1.08M
-Change in receivables --------2,300.00%96K--0--0---------85.19%4K125.86%131K--0
-Change in prepaid assets 140.25%192K-43.70%134K195.12%363K205.58%284K186.49%318K-232.50%-477K401.27%238K209.82%123K26.50%-269K-45.59%111K
-Change in payables and accrued expense 93.81%-160K-570.83%-644K-60.24%-5.54M71.73%-255K-96.98%-2.61M-815.79%-2.58M93.98%-96K-449.29%-3.46M-127.38%-902K-256.57%-1.32M
-Change in other current assets --0--00.00%481K-76.40%21K-41.98%76K59.40%212K34.38%172K-68.99%481K-30.47%89K670.59%131K
Cash from discontinued investing activities -15.75M0
Operating cash flow 83.13%-1.11M69.89%-1.87M47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.21%-40.61M18.39%-7.04M-25.14%-9.92M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow ----------10.4M--0--10.4M----------0--0----
Financing cash flow
Cash flow from continuing financing activities 17,224.14%5.02M00-99.91%29K-85.88%12K0
Net common stock issuance ------------------0------------------0
Proceeds from stock option exercised by employees --------17,224.14%5.02M41,566.67%5M--0---------89.72%29K-85.88%12K--0
Cash from discontinued financing activities
Financing cash flow --------17,224.14%5.02M--0--0---------99.91%29K-85.88%12K--0
Net cash flow
Beginning cash position -20.55%5.7M-43.42%7.57M-75.20%13.38M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M-7.33%53.96M-67.35%20.41M-56.92%30.32M
Current changes in cash 27.76%-1.11M69.89%-1.87M85.66%-5.82M78.08%-1.54M134.97%3.47M85.83%-1.53M51.59%-6.21M-849.29%-40.58M17.72%-7.03M-25.71%-9.92M
Effect of exchange rate changes -166.67%-2K-500.00%-4K166.67%8K-50.00%4K--0400.00%3K200.00%1K-25.00%3K166.67%8K---3K
End cash Position -18.67%4.59M-20.55%5.7M-43.42%7.57M-43.42%7.57M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M-75.20%13.38M-67.35%20.41M
Free cash flow 83.13%-1.11M69.89%-1.87M47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.19%-40.61M18.39%-7.04M-25.03%-9.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg